Background: Capsular contracture induced by chronic subclinical infection is a major cause of poor outcomes and reoperation in breast implant surgery. The use of pocket irrigation with antiseptic/antibiotic has been shown to reduce the incidence of contracture. A new formulation of hypochlorous acid solution PhaseOne has been proposed as potential agent for irrigation. Objectives: This study aimed to test the efficacy of hypochlorous acid solution PhaseOne for use in breast pocket irrigation as an alternative to povidone iodine solution Betadine. Methods: The efficacy of PhaseOne, a hypochlorous acid formulated wound and skin cleanser, was tested in vitro against planktonic and biofilm Staphylococcus aureus with or without biological soil and in an implant attachment assay. Its activity was compared with Betadine containing 10% povidone iodine. Results: Our findings showed that PhaseOne was unable to eradicate planktonic and/or biofilm S. aureus in the presence of either tryptone soy broth or bovine calf serum (protein soil) in a variety of in vitro assays. Conclusions: We advise that povidone iodine containing irrigants are superior to hypochlorous acid containing irrigants in the clinical setting and should remain the recommended solution for pocket irrigation to reduce bacterial contamination at breast implants surgery.
There is increasing evidence to support the importance of device-associated infection as a cause of poor outcomes following prosthetic surgery. 1 For breast implants, the pathway from contamination at the time of surgery to capsular contracture has been studied and is supported by strong laboratory and clinical evidence. 2, 3 More importantly, the use of anti-infective strategies is starting to show significant translational benefits to patients in reducing the rates of capsular contracture and reoperation. 4, 5 One clinical strategy that is increasingly being utilized by surgeons is pocket irrigation to reduce the level of bacterial contact with implants prior to their insertion. This was first described by Boyd Burkhardt 6 and then further studied by to show a quantitative reduction in bacterial recovery within the breast implant pocket. Two recent clinical studies have shown that pocket irrigation using either povidone iodine alone or povidone iodine mixed with topical antibiotics resulted in a 10-fold reduction in capsular contracture. 4, 5 The detection of a Gram-negative microbiome in breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) samples 10 has also further increased interest in anti-infective strategies and led to a debate as to the best choice for pocket irrigation. The recent release of an FDA approved topical preparation of diluted hypochlorous acid 11 solution PhaseOne (Integrated Healing Technologies, Franklin, TN) has corresponded with the clinical recommendation to utilize this product in pocket irrigation. We sought to compare the in vitro effectiveness of PhaseOne containing 0.025% hypochlorous acid with Betadine solution (Purdue Pharma, Stamford, CT) containing 10% povidone iodine utilizing proven biocide testing models.
METHODS
The commercially available hypochlorous acid solution 235 mL PhaseOne bottle, and 100 mL Betadine bottle were kindly provided by a plastic surgeon.
The study was conducted from April 3 to May 12, 2017 and June 10 to 30, 2017. The date of testing was checked within product expiry date and a new 235 mL bottle of PhaseOne was opened for the second period of study.
Determining Minimum Inhibitory Concentration, Minimum Eradication Concentration, Minimum Biofilm Inhibition, and Eradication Concentration
One bacterial colony of Staphylococcus aureus (strain ATCC 25923) was inoculated into 100% tryptone soya broth (TSB) (Oxoid, Adelaide, Australia) and shaken overnight at 37°C. To determine the minimum inhibitory concentration (MIC), the overnight culture was diluted in TSB and 100 µL containing 10 7 bacterial cells added each well in 96 well plates. The commercially available products (PhaseOne and Betadine) were used neat or diluted to give varying concentrations of test antiseptic (50%, 25%, 12.5%, 6.25%, 3.13%, 1.56%, and 0.78%). A 100 µL aliquot of neat or diluted antiseptic was added to wells containing 100 µL of bacterial TSB. The plate was incubated at 37°C for 24 hours. The MIC is the dilution at which no growth occurs. Due to the experiment setting, the concentration tested was halved from antiseptic added to each well.
For each well of the MIC plate that showed no growth, a 20 µL aliquot was added to 180 µL TSB in a clean plate and incubated for 24 hours. The minimum eradication concentration (MEC) is the dilution at which no growth occurs, ie, all the bacteria in the transferred 20 µL aliquot were dead.
To test for the minimum biofilm inhibition concentration (MBIC), S. aureus was diluted to give 10 6 /mL, 100 µL was added into 96 well plates and incubated overnight at 37°C which gave approximately 10 7 biofilm cells attached to the well sides. The planktonic cells were removed, 100 µL of dilutions of test products (PhaseOne and Betadine) were then added with 100 µL of TSB and incubated at 37°C overnight. The MBIC is the product dilution at which there is no release of planktonic cells into the media.
For each well of the MBIC plate that showed not growth, a 20 µL aliquot was added to 180 µL TSB in a clean plate and incubated for 24 hours. The minimum biofilm eradication concentration (MBEC) is the product dilution that no growth occurs.
MBEC Device Assay
The MBEC device (Innovotech, Edmonton, Canada) was used according to ATSM standard protocol E2799 12 to test the efficacy of PhaseOne or Betadine against S. aureus with or without addition of 5% bovine calf serum (BCS) (Sigma) to simulate presence of biological soil. To test products with 5% BCS, 5 µL of BCS was added to 95 µL of neat or diluted test antiseptic before testing. Contact time was for 15 minutes and 24 hours.
Efficacy Against 3-Day Hydrated Biofilms Produced Under Shear
S. aureus biofilm was grown on polycarbonate coupons in a Centers for Disease Control biofilm reactor (BioSurface Technologies Corp., Bozeman, MT), in 500 mL of 50% TSB under shear (130 rpm) at 35°C in batch phase for 48 hours, followed by fresh media (20% TSB) for a further 24 hours. Coupons were washed in 10 mL phosphate buffered saline (PBS) to remove loosely attached planktonic bacteria. Each coupon was covered with an average of 10 7 S. aureus biofilm cells. Biofilm covered coupons (n = 3/test group) were immersed in 2 mL undiluted test products for 15 minutes with and without the addition of 5% BCS.
Bacterial Attachment Assay on Breast Implants
Sterile, 5 mm circular textured breast implant (Siltex, Mentor) pieces were floated on TSB containing 5% BCS and 10 6 /mL S. aureus for 5 minutes to simulate contamination during surgery. The implant shells were placed in 15 mL of full strength test antiseptics for 15 minutes with and without the presence of 5% BCS. The implants were removed and antiseptic action neutralized by addition of 10% bovine serum albumin (BSA). Five mini implant pieces were placed in 1 mL of PBS and subjected to sonication at 43 KHz (Soniclean, Thebarton, South Australia, Australia) for 10 minutes, and the number of live bacteria attached to the implant surface was determined by standard plate culture and colony forming units (cfu). Each test condition was tested in triplicate. Figure 1 summarizes the MBEC results for test antiseptics both in the presence and absence of soil (5% BCS) with 15 minutes and 24 hours contact time.
RESULTS

MIC, MEC, MBIC, and MBEC
MBEC Device Assay
The results show that in the presence of BCS, PhaseOne was not effective at eradicating biofilm bacteria after 15 minutes of treatment, but that a dilution of 50% was effective at 24 hours contact time. By contrast, a 3.1% dilution and 0.78% dilution of Betadine was effective in the presence of BCS for eradicating biofilm bacteria at 15 minutes and 24 hours contact time respectively.
Efficacy Against 3-Day Hydrated Biofilms Produce Under Shear
Results are summarized in Table 2 . PhaseOne was not effective in eliminating S. aureus after 15 minutes of contact time in the presence of BCS. By contrast, Betadine showed good activity eliminating all bacteria after 15 minutes of contact time with and without the addition of BCS.
Breast Implant Attachment Assay
The results are summarized in Table 3 . PhaseOne was not effective in eliminating S. aureus after 15 minutes of contact time in the presence of BCS. By contrast, Betadine showed good activity eliminating all bacteria after 15 minutes of contact time with and without the addition of BCS.
DISCUSSION
The attachment of bacteria to breast implants and proliferation of biofilm over time is a key factor in the genesis of host inflammation and contracture. 13 Bacteria within this biofilm environment are more resistant to antibiotics and antimicrobials and so prevention of bacteria contacting the implant is the key. 1 The use of an ideal antiseptic/antibiotic combination that successfully reduces the likelihood of bacterial presence in the breast implant pocket has been shown to reduce the formation of contracture. 4, 5 It is important that surgeons are basing their clinical practice on proven irrigants, which are tested under appropriate conditions to ensure maximal efficacy.
Our findings have shown that PhaseOne (0.025% hypochlorous solution) was unable to inhibit or eradicate the planktonic bacteria or biofilm in the presence of either tryptone soy broth or bovine calf serum in a variety of in vitro assays. Both these solutions represent a protein soil, which provide bacteria with a source of nutrition to proliferate and simulate intraoperative conditions within the breast pocket. Hypochlorous acid is a compound released by activated neutrophils as part of the human immune system in response to infection. 14, 15 It works by oxidization of the bacterial cells reducing their capacity for replication. 15 The Therapeutic Goods Act (1989) for Standard for Disinfectants and Sterilants 16 suggests the use of 5% serum as standard biological Figure 1 . MBEC assay comparing activity of PhaseOne (0.025% hypochlorous acid) and Betadine (10% povidone iodine) against S. aureus after 15 minutes and 24 hours contact time with and without the addition of 5% BCS to simulate protein soil. 100% = neat solution. PhaseOne was not able to kill biofilm bacteria with a 15 minutes contact time in the presence of 5% BCS.
soil for disinfectant testing, in an attempt to simulate in use application of these products. The presence of proteins can act as neutralizers, absorbing the oxidizing capacity of hypochlorous acid further protecting bacteria against its direct attack. Our findings mirror previous works which confirmed that the presence of blood reduced the activity of hypochlorous acid significantly rendering it ineffective in killing bacterial pathogens. 17 This study also showed a dilutional effect which also served to reduce hypochlorous acid efficacy. 17 This is further evidence that the activity of hypochlorous acid is significantly impacted by the presence of additional proteins and blood. The results for the attachment assay on breast implants showed that 1 × 10 5 bacterial cells were able to attach to 1 cm 2 of the textured breast implants and that while PhaseOne was able to prevent bacterial attachment in the absence of soil, its efficacy was significantly decreased in the presence of protein soil. By contrast, under the conditions of this test, which mimics more closely conditions during surgery, Betadine was able to completely prevent bacterial attachment on breast implant shells even in the presence of protein soil.
Our study also demonstrated the superior efficacy of Betadine solution in both inhibition and eradication of S. aureus biofilms than PhaseOne Solution. This is consistent with other study which demonstrates the greater biofilm remover capacity of Povidone-iodine ointment than other topical wound agents tested. 18 We acknowledge that there are concern about the cytotoxicity of Betadine on human keratinocytes and fibroblasts cells and wound healing. A review article on betadine which shows that there are conflicting clinical studies on its cytotoxicity 19 and an in vitro study demonstrated that 1:10 diluted Betadine solution effective against both Pseudomonas aeruginosa and Staphylococcus aureus and no harm to human fibroblast cells. 20 Since 2000, the use of Betadine solution in breast implant pocket irrigation was contraindicated by the US Food and Drug Administration (FDA). Many surgeons have used betadine containing irrigations off-label since the label restriction. Recently, the betadine label contraindication for Allergan implants was removed on August 28, 2017 after the company submitted long term data for evaluation. It is anticipated that the same label modification will be made in the future for additional US manufacturers.
CONCLUSIONS
In conclusion, after a head to head comparison, we would strongly advise that surgeons should continue to use povidone iodine containing irrigants to reduce bacterial load around breast implants. These have been shown to be effective in reducing capsular contracture in clinical studies and we caution against a switch to other products in the absence of good in vitro and in vivo evidence to suggest otherwise.
We acknowledge that in vitro testing does not always translate directly to clinical setting and call for more detailed prospective clinical studies if the claim is to be made that PhaseOne is better than betadine in reducing biofilm contamination and/or contracture.
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